GOALS & OBJECTIVES
Emerging Paradigms in the Management of Leukemias and Lymphomas
Based on proceedings from a roundtable symposium held in Orlando, Florida
Activity Date: May 2007  — Activity Info: Volume7, (4)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired)

 
GOAL
To provide pharmacists and nurses specializing in hematology/oncology with up-to-date information on the treatment and management of patients with hematologic malignancies.

TARGET AUDIENCE
This activity is designed for pharmacists and nurses specializing in hematology/oncology. No prerequisites required.

LEARNING OBJECTIVES
The Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing, and The University of Tennessee College of Pharmacy take responsibility for the content, quality, and scientific integrity of this CE activity. At the conclusion of this activity, the participant should be able to:
  • Identify the new products for use in hematologic malignancies and describe their specific pharmacokinetic profiles.
  • Explain the pros and cons of each of the treatment options for acute myelogenous leukemia, myelodysplastic syndromes, acute promyelocytic leukemia, non-HodgkinÕs lymphoma, and multiple myeloma.
  • Apply the decision-making process for the selection of drugs in the different patient populations.
  • Describe the constraints that use of the different therapies brings to each of the disease states, including the side effects and risks associated with each of the agents.
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing, and the University of Tennessee College of Pharmacy. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses' Credentialing Center's Commission on Accreditation.

The University of Tennessee College of Pharmacy (UTCOP) is accredited by the Accreditation Council of Pharmacy Education (ACPE) to provide continuing education for pharmacists.

CREDIT DESIGNATION STATEMENT
This 2 contact hour Educational Activity (Provider Directed/Learner Paced) is provided by The Institute for Johns Hopkins Nursing. Claim only those contact hours actually spent in the activity.

This program is approved for 2 hours of credit (0.2 CEUs) and is sponsored by the University of Tennessee College of Pharmacy, which is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE program # 064-999-07-220-H01.

The estimated time to complete this educational activity: 2 hours.

Release date: May 15, 2007. Expiration date: May 15, 2009.

DISCLAIMER STATEMENT
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of The Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing, and the University of Tennessee College of Pharmacy names implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

This program is supported by an educational grant from Cephalon Oncology.
     
Home | Contact Us | View Account | Need Help?